Alcimed’s goal is to promote mental health and improve the patient pathway to address the increasing prevalence / diagnosis in psychiatric disorders, and the pressure imparted on healthcare systems. Our specialized team supports public and private healthcare players in exploring sustainable solutions based on the latest research and innovation.

L’article Mental Health est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their digital therapeutics projects, from understanding the technologies and target markets, to defining access strategies and redesigning care pathways.

L’article Digital Therapeutics (DTx) est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in exploring the potential of radiopharmaceutical products, from understanding services and devices that could facilitate their use in care centers, to implementing commercial strategies that ease the adoption of nuclear medicine and radiotherapy in patient pathways.

L’article Radiopharmaceuticals est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their projects to innovate and develop CAR-T cell therapies, from optimizing R&D to ensuring market access and patient care management.

L’article CAR-T cells est apparu en premier sur Alcimed.

Our specialized team supports healthcare players understand the regenerative biotherapy market and seize its potential through various projects related to stem cells and tissue engineering.

L’article Regenerative medicine est apparu en premier sur Alcimed.

Our specialized team supports players in the medico-social sector on the theme of loss of independence, particularly focusing on challenges related to the need of care of older people.

L’article Loss of autonomy est apparu en premier sur Alcimed.

Our specialized team explores opportunities to improve clinical trials, and in particular supports pharma players in their innovation projects around the digitalization of clinical studies, from preliminary research phases to real-world observations.

L’article Digital clinical trials est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in understanding and improving the therapeutic and emotional journey of patients, as well as the role and coordination of key stakeholders (healthcare professionals, patient associations, family members or caregivers, etc.), from pre-diagnosis to palliative care, in both outpatient and hospital settings.

L’article Patient pathway est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their patient experience projects to better measure and manage the patient experience, to improve their experience along the care pathway, and to create new experiences or new solutions.

L’article Patient experience est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in projects related to the concept of Value-Based Healthcare, from identifying its impacts and associated opportunities, exploring new reimbursement models, addressing issues linked to patients’ quality of life, to improving patient pathways to bring more value to the different stakeholders throughout the journey.

L’article Value-based healthcare est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in harnessing the potential of translational research to accelerate the development of their innovative therapies.

L’article Translational research est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their innovation and development projects related to gene therapy drugs, from research to pharmaceutical development through to market launch.

L’article Gene therapy est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in exploring RNA technologies, the potential for their therapeutic use, and questions relating to their applications, particularly since recent advances in mRNA therapies.

L’article Messenger RNA est apparu en premier sur Alcimed.

Our specialized team brings its expertise on patient centricity to healthcare players and supports them in defining their global patient-centric approaches and in realizing their projects related to this theme.

L’article Patient centricity est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their homecare innovation and development projects, from understanding the different segments of the homecare market to bringing new products or services to market.

L’article Homecare est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their innovation and development projects linked to the HealthTech market, whether to develop new drugs, new diagnostic solutions, new medical devices and equipment, or new services for patients and healthcare professionals.

L’article HealthTech est apparu en premier sur Alcimed.

Our specialized team helps manufacturers explore the opportunities offered by synthetic biology in various fields of research and application, in order to create new biological functions, new organisms or new materials with novel properties.

L’article Synthetic biology est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their innovation projects related to the Point Of Care Testing market, helping them understand this rapidly growing sector, define their positioning, and launch their POCT solutions.

L’article Point of Care Tests (POCT) est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their innovation and development projects linked to the genome editing technologies market, from understanding trends and challenges to market access strategies.

L’article Genome editing est apparu en premier sur Alcimed.

Our specialized team supports public-sector and non-profit players in their innovation projects related to healthy aging, and in understanding needs and enhancing practices for healthcare professionals, beneficiaries, relatives and caregivers.

L’article Healthy aging est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their innovation and development projects in the field of monoclonal antibodies, from chronic diseases to the use of bispecific antibodies for tumor targeting.

L’article mAbs est apparu en premier sur Alcimed.

Our specialized team explores the field of rare cancers such as sarcomas and various types of carcinoma, and supports healthcare players in identifying patients, improving care pathways, developing research and bringing new treatments to market.

L’article Rare cancers est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their projects to innovate, understand and gain access to orphan drug markets.

L’article Rare diseases est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in exploring the field of women’s health and their projects related to understanding women’s diseases, their causes, treatments, and associated care pathways as well as driving innovation in this area.

L’article Women’s health est apparu en premier sur Alcimed.

Our specialized team supports consumer healthcare players in their innovation and development projects to meet the challenges and seize the opportunities of this booming market.

L’article Consumer healthcare est apparu en premier sur Alcimed.

Our specialized team supports animal health players in their innovation projects, development strategies in their markets, new product launches, identification of new partners, technology scouting for research, and more.

L’article Animal health est apparu en premier sur Alcimed.

Our specialized team helps healthcare players seize the opportunities offered by companion diagnostics, assess their potential, build their development roadmaps and integrate them into their care pathways.

L’article Companion diagnostics (CDx) est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their projects involving artificial intelligence and data strategies, from the application of AI in the R&D phases to the deployment of new AI-based solutions (such as predictive medicine, personalized medicine, AI-based diagnostics and therapies, robot companions, computer assisted surgery, prevention tools, and others).

L’article AI in healthcare est apparu en premier sur Alcimed.

Our specialized team explores patient advocacy and patient-centric approaches to support healthcare players in understanding how patient advocacy groups can contribute to R&D, market access, and the improvement of the patient journey for new pharmaceutical products and diagnostics.

L’article Patient advocacy est apparu en premier sur Alcimed.

Our specialized team explores the opportunities offered by the digitalization of R&D activities in the pharmaceutical industry, and helps healthcare players understand the challenges and opportunities linked to advanced computing in R&D.

L’article Advanced computing est apparu en premier sur Alcimed.

Our specialized team explores the potential applications of chatbots in the healthcare field, and supports industry players in their projects related to the development, implementation and assessment of AI chatbots.

L’article Healthcare chatbots est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in the promising field of personalized and precision medicine, from R&D and market access phases to its adoption by healthcare professionals and patients.

L’article Personalized medicine est apparu en premier sur Alcimed.

Thanks to our in-depth knowledge of the article 51 system, we can help companies in the construction of their projects with a view to the successful submission of their experiment within the framework of Article 51.

L’article Article 51 est apparu en premier sur Alcimed.

Our specialized team works on the drivers and barriers to access to medicines, and supports healthcare players in building wider access to treatments.

L’article Access to medicines est apparu en premier sur Alcimed.

Our specialized team explores the challenges and opportunities associated with biotherapies, and supports healthcare players in accelerating the research, development and market launch of their innovative biotherapies.

L’article Innovative biotherapeutics est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in understanding new technologies that could improve cancer treatment pathways, whether through projects related to quality of life, improving and accelerating diagnostics, predicting treatment success, or developing new biomarkers.

L’article Radiomics est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their projects related to Virtual Care, particularly telemedicine, which has grown significantly in practice since the Covid-19 pandemic.

L’article Telemedicine est apparu en premier sur Alcimed.

Our specialized team explores the public health challenges posed by the global health crisis of antibiotic resistance, and supports healthcare players in their projects to develop new approaches to treatment and diagnosis, and to optimize access to treatment.

L’article Antibiotic resistance est apparu en premier sur Alcimed.

Our specialized team explores the opportunities offered by self-diagnostic tools and supports healthcare professionals in their innovation and development projects to optimize pathology detection and accelerate patient care.

L’article Self-diagnosis est apparu en premier sur Alcimed.

Our specialized team supports companies in their projects related to the microbiome market, whether it’s conducting a scientific state of the art, guiding R&D programs, searching for partners, defining a commercial strategy, or launching new products.

L’article Microbiome est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their innovative projects related to e-health and the integration of digital technology across the entire value chain, from R&D to interaction with clients, patients and prescribers.

L’article Digital health est apparu en premier sur Alcimed.

Our specialized team supports pharmaceutical, materials, food and cosmetics manufacturers in their biomanufacturing projects to develop a more sustainable and responsible approach to production.

L’article Bioproduction est apparu en premier sur Alcimed.